betaine has been researched along with c 31g in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (16.13) | 18.7374 |
| 1990's | 9 (29.03) | 18.2507 |
| 2000's | 12 (38.71) | 29.6817 |
| 2010's | 5 (16.13) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ayhan, A; Calis, S; Hincal, AA; Sumnu, M; Yulug, N | 1 |
| Caliş, S; Hincal, AA; Sumnu, M; Unlü, N | 1 |
| Rotgans, J; Stickforth, P | 1 |
| Brightman, VJ; Cooper, S; Corner, AM; Malamud, D; Yankell, SL | 1 |
| Corner, AM; Dolan, MM; Malamud, D; Yankell, SL | 1 |
| Douglas, DM; Hamilton, SG; Kenyon, AJ | 1 |
| Amin, MM; Anderson, KL; Gustafsson, BK; Hahn, EC; Smith, AR | 1 |
| Hahn, EC; Kenyon, AJ; Michaels, EB | 2 |
| Caliş, S; Hincal, AA; Sumnu, M | 1 |
| Malamud, D; Storey, BT; Thompson, KA | 1 |
| Addy, M; Doherty, FM; Moran, J; Newcombe, RG; Renton-Harper, P | 1 |
| Davis, CH; Gerbig, DG; Knight, ST; Malamud, D; Paul, TR; Raulston, JE; Wyrick, PB | 1 |
| Howett, MK; Krebs, FC; Malamud, D; Miller, SR; Wigdahl, B | 1 |
| Catalone, BJ; Howett, MK; Krebs, FC; Malamud, D; Miller, SR; Welsh, PA; Wigdahl, B | 1 |
| Anderson, D; Catalone, BJ; Fichorova, R; Howett, MK; Krebs, FC; Malamud, D; Miller, SR; Wigdahl, B | 1 |
| Bax, R; Bowden, M; Douville, K; Higgins, J; McCormick, D; Rosenberg, M | 1 |
| Archer, DF; Baker, JM; Ballagh, SA; Henry, DM | 1 |
| Bax, R; Callahan, MM; Frezieres, RG; Mauck, CK; Schmitz, SW; Walsh, TL | 1 |
| Archer, DF; Ballagh, SA; Barnhart, KT; Bax, R; Callahan, MM; Creinin, MD; Mauck, CK; Schmitz, SW | 1 |
| Barnhart, KT; Bax, R; Callahan, MM; Creinin, MD; Mauck, CK; Weiner, DH | 1 |
| Budgeon, LR; Catalone, BJ; Ferguson, ML; Howett, MK; Kish-Catalone, TM; Krebs, FC; Malamud, D; Miller, SR; Neely, EB; Stiller, C; Wigdahl, B | 1 |
| Barnhart, KT; Malamud, D; Pretorius, ES; Shabbout, M; Shera, D; Timbers, K | 1 |
| Catalone, BJ; Ferguson, ML; Howett, MK; Kish-Catalone, T; Krebs, FC; Malamud, D; Miller, SR; Thakkar, NJ; Wigdahl, B | 2 |
| Balkus, JE; Hillier, SL; Patton, DL; Sweeney, YT | 1 |
| Archer, D; Barnhart, K; Blithe, D; Burke, AE; Carr, BR; Creinin, MD; Jensen, JT; Liu, J; Schlaff, W; Thomas, M; Walsh, TL; Wan, LS; Westhoff, C; Wu, H | 1 |
| Ampofo, W; Feldblum, PJ; Halpern, V; Lie, CC; Obunge, O; Ogunsola, F; Opoku, K | 1 |
| Bhattacharjee, PS; Clement, C; Foster, TP; Hill, JM; Lukiw, WJ; Malamud, D; McFerrin, HE; Ochoa, AC; Rodriguez, P; Stern, EM; Velasco, C | 1 |
| Choi, IS; Kang, BH; Kang, JH; Lee, DH; Lee, JB; Lee, SW; Park, JK; Park, SY; Song, CS; Youn, HN | 1 |
| Gkatzonis, AM; Kaminari, A; Karoussis, IK; Madianos, PN; Vassilopoulos, SI; Vrotsos, IA | 1 |
11 trial(s) available for betaine and c 31g
| Article | Year |
|---|---|
[The effect of a chemotherapeutical amine containing toothpaste on plaque formation, gingivitis and caries in clinical and animal experiment].
Topics: Analysis of Variance; Animals; Betaine; Dental Caries; Dental Plaque; Double-Blind Method; Evaluation Studies as Topic; Fatty Acids, Unsaturated; Gingivitis; Humans; Rats; Toothpastes | 1991 |
Clinical study of a C31G containing mouthrinse: effect on salivary microorganisms.
Topics: Adult; Analysis of Variance; Anti-Bacterial Agents; Bacteria; Betaine; Dental Plaque; Drug Combinations; Fatty Acids, Unsaturated; Glycolysis; Humans; Mouthwashes; Salicylates; Saliva; Streptococcus; Terpenes | 1990 |
A comparison of chlorhexidine, cetylpyridinium chloride, triclosan, and C31G mouthrinse products for plaque inhibition.
Topics: Adult; Anti-Infective Agents, Local; Betaine; Cetylpyridinium; Chlorhexidine; Cross-Over Studies; Dental Plaque; Fatty Acids, Unsaturated; Female; Humans; Male; Maleates; Mouthwashes; Polyvinyls; Single-Blind Method; Triclosan | 1996 |
Microbicides--evaluating multiple formulations of C31G.
Topics: Administration, Intravaginal; Adolescent; Adult; Anti-Infective Agents; Betaine; Chemistry, Pharmaceutical; Drug Administration Schedule; England; Fatty Acids, Unsaturated; Female; Humans; Middle Aged; North Carolina; Patient Satisfaction; Pennsylvania; Sexually Transmitted Diseases | 2002 |
Safety of single daily use for one week of C31G HEC gel in women.
Topics: Administration, Intravaginal; Adult; Anti-Infective Agents; Betaine; Cellulose; Colposcopy; Double-Blind Method; England; Fatty Acids, Unsaturated; Female; Gels; Humans; North Carolina; Patient Satisfaction; Pennsylvania; Sexually Transmitted Diseases; Surveys and Questionnaires; Treatment Outcome; Vagina | 2002 |
Male tolerance study of 1% C31G.
Topics: Adult; Betaine; Circumcision, Male; Double-Blind Method; Fatty Acids, Unsaturated; Gels; Humans; Male; Nonoxynol; Patient Satisfaction; Penis; Spermatocidal Agents; Surveys and Questionnaires | 2004 |
A phase I comparative postcoital testing study of three concentrations of C31G.
Topics: Adult; Betaine; Cervix Mucus; Dose-Response Relationship, Drug; Double-Blind Method; Fatty Acids, Unsaturated; Female; Humans; Middle Aged; Sperm Motility; Spermatocidal Agents; Vagina | 2004 |
A randomized Phase I vaginal safety study of three concentrations of C31G vs. Extra Strength Gynol II.
Topics: Adolescent; Adult; Anti-Infective Agents; Betaine; Colposcopy; Double-Blind Method; Fatty Acids, Unsaturated; Female; Genitalia, Female; Humans; Middle Aged; Nonoxynol; Patient Satisfaction; Spermatocidal Agents; Vagina; Vaginitis | 2004 |
Distribution of a 3.5-mL (1.0%) C31G vaginal gel using magnetic resonance imaging.
Topics: Administration, Intravaginal; Adult; Betaine; Coitus; Fatty Acids, Unsaturated; Female; Humans; Magnetic Resonance Imaging; Mucous Membrane; Pilot Projects; Spermatocidal Agents; Vagina; Vaginal Creams, Foams, and Jellies | 2005 |
Contraceptive efficacy, acceptability, and safety of C31G and nonoxynol-9 spermicidal gels: a randomized controlled trial.
Topics: Adolescent; Adult; Betaine; Double-Blind Method; Fatty Acids, Unsaturated; Female; Gels; Humans; Nonoxynol; Pregnancy; Spermatocidal Agents; Young Adult | 2010 |
A randomized controlled clinical trial on the effectiveness of three different mouthrinses (chlorhexidine with or without alcohol and C31G), adjunct to periodontal surgery, in early wound healing.
Topics: Adult; Aged; Betaine; Chlorhexidine; Double-Blind Method; Ethanol; Fatty Acids, Unsaturated; Female; Humans; Male; Middle Aged; Mouthwashes; Periodontal Diseases; Real-Time Polymerase Chain Reaction; Surgical Flaps; Treatment Outcome; Wound Healing | 2018 |
20 other study(ies) available for betaine and c 31g
| Article | Year |
|---|---|
A non-antibiotic antimicrobial mixture (C31G): evaluation of the antimicrobial efficiency of C31G on vaginal cultures.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Betaine; Drug Combinations; Fatty Acids, Unsaturated; Female; Fungi; Humans; Microbial Sensitivity Tests; Surface-Active Agents; Vagina | 1992 |
Evaluation of the interfacial properties of a new potent antimicrobial surfactant C31G.
Topics: Anti-Infective Agents; Betaine; Chemical Phenomena; Chemistry, Physical; Fatty Acids, Unsaturated; Surface-Active Agents | 1991 |
C31G, a new agent for oral use with potent antimicrobial and antiadherence properties.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Adhesion; Betaine; Fatty Acids, Unsaturated; Glycolysis; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Mouthwashes | 1988 |
Controlled wound repair in guinea pigs, using antimicrobials that alter fibroplasia.
Topics: Animals; Anti-Infective Agents; Betaine; Chlorine; Chlorine Compounds; Collagen; Disinfectants; Fatty Acids, Unsaturated; Guinea Pigs; Oxides; Staphylococcal Infections; Surface-Active Agents; Surgical Wound Infection; Tensile Strength; Wound Healing | 1986 |
Evaluation of a surfactant mixture C31G as a teat dip by a modified excised teat model.
Topics: Animals; Anti-Bacterial Agents; Betaine; Cattle; Disinfection; Enterococcus faecalis; Escherichia coli; Fatty Acids, Unsaturated; Female; Iodophors; Mammary Glands, Animal; Mastitis, Bovine; Staphylococcus aureus; Sterilization | 1984 |
Mice and rabbit models for oral and percutaneous absorption and disposition of amphoteric surfactant C31G.
Topics: Absorption; Administration, Oral; Administration, Topical; Animals; Betaine; Body Burden; Fatty Acids, Unsaturated; Female; Mice; Mice, Inbred Strains; Mouth Mucosa; Rabbits; Skin Absorption; Tissue Distribution; Tritium | 1983 |
Effect of C31G, an antimicrobial surfactant, on healing of incised guinea pig wounds.
Topics: Animals; Betaine; Fatty Acids, Unsaturated; Guinea Pigs; Skin; Staphylococcal Infections; Surface-Active Agents; Wound Healing; Wounds, Penetrating | 1983 |
Effect of suppository bases on the release properties of a potent antimicrobial agent (C31G).
Topics: Alkalies; Anti-Bacterial Agents; Betaine; Chemistry, Pharmaceutical; Escherichia coli; Fatty Acids, Unsaturated; Microbial Sensitivity Tests; Pessaries; Pharmaceutical Vehicles; Staphylococcus; Triglycerides | 1994 |
Assessment of the anti-microbial agent C31G as a spermicide: comparison with nonoxynol-9.
Topics: Adult; Anti-Infective Agents; Betaine; Cell Membrane Permeability; Cervix Mucus; Fatty Acids, Unsaturated; Fluorescent Dyes; Humans; Male; Nonoxynol; Spermatocidal Agents; Spermatozoa | 1996 |
The microbicidal agent C31G inhibits Chlamydia trachomatis infectivity in vitro.
Topics: Anti-Bacterial Agents; Betaine; Cell Line; Chlamydia Infections; Chlamydia trachomatis; Endothelium; Fatty Acids, Unsaturated; Humans | 1997 |
Inactivation of human immunodeficiency virus type 1 by nonoxynol-9, C31G, or an alkyl sulfate, sodium dodecyl sulfate.
Topics: Anti-HIV Agents; Betaine; Cell Line; Drug Interactions; Fatty Acids, Unsaturated; HeLa Cells; HIV-1; Humans; Lymphocytes; Macrophages; Nonoxynol; Sodium Dodecyl Sulfate; Surface-Active Agents; Time Factors | 1999 |
Sodium dodecyl sulfate and C31G as microbicidal alternatives to nonoxynol 9: comparative sensitivity of primary human vaginal keratinocytes.
Topics: Anti-Infective Agents; Betaine; Cell Survival; Cells, Cultured; Fatty Acids, Unsaturated; Female; Humans; Keratinocytes; Keratins; Nonoxynol; Sodium Dodecyl Sulfate; Surface-Active Agents; Vagina | 2000 |
Comparative in vitro sensitivities of human immune cell lines, vaginal and cervical epithelial cell lines, and primary cells to candidate microbicides nonoxynol 9, C31G, and sodium dodecyl sulfate.
Topics: Betaine; Cell Line; Cell Survival; Fatty Acids, Unsaturated; Female; Granulocyte-Macrophage Colony-Stimulating Factor; HeLa Cells; Humans; Macrophage Colony-Stimulating Factor; Macrophages; Monocytes; Nonoxynol; Sodium Dodecyl Sulfate; Surface-Active Agents; T-Lymphocytes; Vagina | 2002 |
Comparative safety evaluation of the candidate vaginal microbicide C31G.
Topics: Administration, Intravaginal; Animals; Anti-Infective Agents, Local; Betaine; Cell Line; Cervix Uteri; Fatty Acids, Unsaturated; Female; HeLa Cells; Humans; Mice; Nonoxynol; Vagina; Vaginal Creams, Foams, and Jellies | 2005 |
Prolonged exposure to the candidate microbicide C31G differentially reduces cellular sensitivity to agent re-exposure.
Topics: Amines; Anti-Infective Agents; Betaine; Cell Membrane; Cell Survival; Dose-Response Relationship, Drug; Drug Tolerance; Fatty Acids, Unsaturated; HeLa Cells; Humans; Membrane Lipids; Nonoxynol; Sodium Dodecyl Sulfate; Time Factors | 2005 |
Toxicity, inflammation, and anti-human immunodeficiency virus type 1 activity following exposure to chemical moieties of C31G.
Topics: Administration, Intravaginal; Amines; Animals; Anti-HIV Agents; Betaine; Cell Line; Cell Survival; Cervix Uteri; Dose-Response Relationship, Drug; Fatty Acids, Unsaturated; Female; HIV-1; Humans; Inflammation; Mice; Models, Animal; Mucous Membrane | 2005 |
Vaginal and rectal topical microbicide development: safety and efficacy of 1.0% Savvy (C31G) in the pigtailed macaque.
Topics: Administration, Intravaginal; Administration, Rectal; Animals; Anti-Infective Agents, Local; Betaine; Cervix Uteri; Chlamydia Infections; Chlamydia trachomatis; Disease Models, Animal; Fatty Acids, Unsaturated; Female; Macaca nemestrina; Rectum; Sexually Transmitted Diseases; Vagina | 2006 |
What predicts non-retention in microbicide trials?
Topics: Adolescent; Adult; Africa South of the Sahara; Age Factors; Anti-Infective Agents, Local; Betaine; Cellulose; Early Termination of Clinical Trials; Fatty Acids, Unsaturated; Female; HIV Infections; Humans; Patient Dropouts; Proportional Hazards Models; Randomized Controlled Trials as Topic; Socioeconomic Factors; Vaginal Creams, Foams, and Jellies; Young Adult | 2011 |
The antimicrobial agent C31G is effective for therapy for HSV-1 ocular keratitis in the rabbit eye model.
Topics: Animals; Antiviral Agents; Betaine; Cornea; Disease Models, Animal; Fatty Acids, Unsaturated; Herpesvirus 1, Human; Humans; Keratitis, Herpetic; Rabbits | 2013 |
In vitro virucidal effect of mouthrinse containing C31G on seasonal influenza viruses.
Topics: Animals; Antiviral Agents; Betaine; Chick Embryo; Dogs; Fatty Acids, Unsaturated; Madin Darby Canine Kidney Cells; Orthomyxoviridae; Viral Load; Virus Cultivation | 2014 |